Pemphigus Treatment

They are different diseases, not variants of one. In pemphigus the antibodies attack desmoglein — a protein INSIDE the epidermis — so the split is shallow, the blisters are flaccid and rupture almost immediately into raw erosions, and the Nikolsky sign is positive. In pemphigoid the antibodies attack BP180 and BP230, the hemidesmosome proteins that anchor the epidermis to the dermis, so the split is deeper, and the blisters are tense and stay intact. Pemphigoid mostly affects people over 70. Pemphigus can begin at any adult age and, in the vulgaris form, usually starts in the mouth. The distinction is made on a biopsy with direct immunofluorescence, and it changes what treatment has to prioritise.

No, and this matters more than anything else on this page. Inherited epidermolysis bullosa is GENETIC — a mutation means the proteins that anchor your skin were never built correctly. It is not an autoimmune disease, and no formulation, Ayurvedic or otherwise, corrects a gene. We do not claim to. The only exception is epidermolysis bullosa ACQUISITA, which is autoimmune and does belong in this group. If nobody has told you which of the two you have, that is the first question to ask your dermatologist.

No — not in Ayurveda, and not in conventional medicine. Anyone who tells you otherwise is selling you something. What is realistic is sustained remission: the disease becoming quiet, and staying quiet, for as long as the internal drivers that generate it stay corrected. That is a realistic goal for many patients — but not for all. We do not promise a cure, and we would rather tell you that before you begin than after.

No, and you must not. Sudden withdrawal of systemic steroids is dangerous, and in a blistering disease it can precipitate a severe flare. Everything you have been prescribed continues. Any reduction is a decision for the doctor who prescribed it, made on the evidence of your own disease activity — never ours, and never yours alone. What we work toward is a disease that is quiet enough that YOUR dermatologist chooses to taper.

There is no fixed timeline, and anyone who gives you one is guessing. The first 4 to 8 weeks are internal work — lowering inflammatory load and repairing the gut barrier — and visible change on the skin is NOT expected during them. Between months 2 and 4 the disease itself should begin to change: fewer new blisters, faster healing of the ones you have, less pain. Stable remission is assessed from month 8 onward. If nothing has moved by month 4, this is not working for you, and we will say so.

For most patients there is no procedure, no in-clinic therapy and no clinic visit. EPOH is entirely formulation-based — oral compounds and topical preparations, compounded to your individual driver profile and couriered to you. You take them at home. That is not a convenience; on raw, eroded, easily-infected skin it is a clinical advantage.

Because the formulation is compounded to your individual driver profile, and naming a constituent invites you to buy it and take it on its own — which is not the treatment and can be actively unsafe alongside immunosuppression. We reference the formulation CATEGORY and the EPOH phase it belongs to. Anything you take is reviewed against the medication you are already on.

Yes, and it is urgent. Mucous membrane (cicatricial) pemphigoid can scar the conjunctiva and threaten sight, and it will not wait. If you have eye involvement — grittiness, redness, scarring, lashes turning inward — you need an ophthalmologist now, alongside your dermatologist. This is not the place to start with supportive care, and we will tell you that.